Jessie Gills

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

Mohamad E. Allaf, Se-Eun Kim, Viraj A. Master et al. · The Lancet Oncology · 2024 · 64 citations · Full text

Urology, Surgical Oncology, Genitourinary Cancer +6

INTACT (S/N1806) phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle-invasive bladder cancer: Safety update on first 73 patients.

Parminder Singh, Jason A. Efstathiou, Catherine M. Tangen et al. · Journal of Clinical Oncology · 2021 · 26 citations

Surgical Oncology, Cancer Management, Gynecology Oncology +16

Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices

Shellie D. Ellis, Mugur Geana, Christine B. Mackay et al. · Urologic Oncology Seminars and Original Investigations · 2019 · 20 citations · Full text

Urology, Community Development, Community Health +13

A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis

Jessie Gills, Ravan Moret, Xin Zhang et al. · Oncotarget · 2018 · 12 citations · Full text